X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA SANOFI INDIA ALEMBIC PHARMA/
SANOFI INDIA
 
P/E (TTM) x 26.6 31.0 85.7% View Chart
P/BV x 6.1 5.5 110.8% View Chart
Dividend Yield % 0.8 1.6 47.1%  

Financials

 ALEMBIC PHARMA   SANOFI INDIA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
SANOFI INDIA
Dec-16
ALEMBIC PHARMA/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs7924,560 17.4%   
Low Rs4434,400 10.1%   
Sales per share (Unadj.) Rs167.01,028.5 16.2%  
Earnings per share (Unadj.) Rs38.2129.0 29.6%  
Cash flow per share (Unadj.) Rs42.0186.0 22.6%  
Dividends per share (Unadj.) Rs4.0068.00 5.9%  
Dividend yield (eoy) %0.61.5 42.7%  
Book value per share (Unadj.) Rs84.9753.6 11.3%  
Shares outstanding (eoy) m188.5223.03 818.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.74.4 84.9%   
Avg P/E ratio x16.234.7 46.6%  
P/CF ratio (eoy) x14.724.1 61.0%  
Price / Book Value ratio x7.35.9 122.3%  
Dividend payout %10.552.7 19.9%   
Avg Mkt Cap Rs m116,383103,174 112.8%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m4,2143,592 117.3%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m31,48723,686 132.9%  
Other income Rs m55708 7.8%   
Total revenues Rs m31,54224,394 129.3%   
Gross profit Rs m10,0605,281 190.5%  
Depreciation Rs m7221,313 55.0%   
Interest Rs m3715 245.3%   
Profit before tax Rs m9,3564,661 200.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1601,691 127.7%   
Profit after tax Rs m7,1942,970 242.2%  
Gross profit margin %31.922.3 143.3%  
Effective tax rate %23.136.3 63.6%   
Net profit margin %22.812.5 182.2%  
BALANCE SHEET DATA
Current assets Rs m15,06615,673 96.1%   
Current liabilities Rs m7,6746,678 114.9%   
Net working cap to sales %23.538.0 61.8%  
Current ratio x2.02.3 83.6%  
Inventory Days Days6776 88.1%  
Debtors Days Days4122 182.1%  
Net fixed assets Rs m8,2378,098 101.7%   
Share capital Rs m377230 163.7%   
"Free" reserves Rs m15,41617,088 90.2%   
Net worth Rs m16,00517,356 92.2%   
Long term debt Rs m00-   
Total assets Rs m24,59425,400 96.8%  
Interest coverage x255.2311.7 81.9%   
Debt to equity ratio x00-  
Sales to assets ratio x1.30.9 137.3%   
Return on assets %29.411.8 250.2%  
Return on equity %44.917.1 262.7%  
Return on capital %58.726.9 217.8%  
Exports to sales %55.724.5 227.6%   
Imports to sales %10.428.0 37.3%   
Exports (fob) Rs m17,5515,801 302.5%   
Imports (cif) Rs m3,2836,627 49.5%   
Fx inflow Rs m17,8117,145 249.3%   
Fx outflow Rs m5,3186,846 77.7%   
Net fx Rs m12,493299 4,178.1%   
CASH FLOW
From Operations Rs m9,3043,226 288.4%  
From Investments Rs m-3,105-1,555 199.7%  
From Financial Activity Rs m-1,959-1,818 107.8%  
Net Cashflow Rs m4,240-147 -2,884.4%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 2.9 14.4 20.1%  
FIIs % 9.1 14.6 62.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 10.5 132.4%  
Shareholders   49,328 15,184 324.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   STRIDES SHASUN LTD  AJANTA PHARMA  UNICHEM LAB  DR. DATSONS LABS  ELDER PHARMA  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 16, 2017 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS